The Glassware Core Facility provides Cancer Center laboratory researchers with clean and sterile glassware for cell culture, molecular biology and biochemistry experiments. In addition to washing and sterilizing glassware for individual laboratories, this facility washes, sterilizes and delivers glass bottles to the Bioreagents and Cell Culture Core Facility for preparation of sterile culture media. The Core also prepares double-deionized and distilled water in large quantities for use in the preparation of reagents and sterilizes pipettes for molecular biology experiments. The Core Facility is located at three sites: the Norris building, the Cancer Research Laboratory (CRL), and the Smith Research Tower at Childrens Hospital Los Angeles (CHLA). The 1,300 sq. ft. Norris space contains two automatic dishwashers, two autoclaves, and a drying oven. The CRL houses a dishwasher and an autoclave in 1,000 sq. ft. The CHLA space has an autoclave and dishwashing facilities. The Glassware Core Facility serves 54 Cancer Center members and their research groups, approximately 350 scientists and technical staff in total. The CCSG supports 4.5 FTE glassware technicians and one is supported by chargebacks. The Glassware Core Facility is supervised by Joseph Landolph, Ph.D., Associated Professor of Molecular Microbiology and Immunology. Mr. Bill Taylor, Director of General Services, is the manager of the daily operations at Norris and CRL. The glassware services at CHLA are overseen by Dr. Ambrose Jong, Ph.D., Associate Professor of Pediatrics and Molecular Microbiology and Immunology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA014089-26S1
Application #
6504883
Study Section
Project Start
2001-04-06
Project End
2001-11-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Ricker, Charité N; Koff, Rachel B; Qu, Chenxu et al. (2018) Patient communication of cancer genetic test results in a diverse population. Transl Behav Med 8:85-94
Valentin-Torres, Alice; Savarin, Carine; Barnett, Joslyn et al. (2018) Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation. J Neuroinflammation 15:121
Tobin, Jessica; Miller, Kimberly A; Baezconde-Garbanati, Lourdes et al. (2018) Acculturation, Mental Health, and Quality of Life among Hispanic Childhood Cancer Survivors: A Latent Class Analysis. Ethn Dis 28:55-60
Jayne, Jordanna G; Bensman, Timothy J; Schaal, Justin B et al. (2018) Rhesus ?-Defensin-1 Attenuates Endotoxin-induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil Recruitment. Am J Respir Cell Mol Biol 58:310-319
Lee, Brian H; Stallcup, Michael R (2018) Different chromatin and DNA sequence characteristics define glucocorticoid receptor binding sites that are blocked or not blocked by coregulator Hic-5. PLoS One 13:e0196965
Harris, Holly R; Babic, Ana; Webb, Penelope M et al. (2018) Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 27:174-182
Woodham, Andrew W; Cheloha, Ross W; Ling, Jingjing et al. (2018) Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses. Cancer Immunol Res 6:870-880
Matsusaka, S; Wu, A H; Cao, S et al. (2018) Prognostic impact of FOXF1 polymorphisms in gastric cancer patients. Pharmacogenomics J 18:262-269
Vannini, Ivan; Fanini, Francesca; Fabbri, Muller (2018) Emerging roles of microRNAs in cancer. Curr Opin Genet Dev 48:128-133
Veyseh, Maedah; Ricker, Charite; Espenschied, Carin et al. (2018) Secondary Germline Finding in Liquid Biopsy of a Deceased Patient; Case Report and Review of the Literature. Front Oncol 8:259

Showing the most recent 10 out of 842 publications